Cetuximab could be more effective without prior bevacizumab treatment in metastatic colorectal cancer patients

Cetuximab could be more effective without prior bevacizumab treatment in metastatic colorectal cancer patients

Yasuyoshi Sato, Satoshi Matsusaka, Mitsukuni Suenaga, Eiji Shinozaki, Nobuyuki Mizunuma Department of Gastroenterology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan Background: Cetuximab and bevacizumab reportedly improve the survival of patients with metastatic...

Full description

Bibliographic Details
Main Authors: Sato Y, Matsusaka S, Suenaga M, Shinozaki E, Mizunuma N
Format: Article
Language:English
Published: Dove Medical Press 2015-11-01
Series:OncoTargets and Therapy
Online Access:https://www.dovepress.com/cetuximab-could-be-more-effective-without-prior-bevacizumab-treatment--peer-reviewed-article-OTT

Internet

https://www.dovepress.com/cetuximab-could-be-more-effective-without-prior-bevacizumab-treatment--peer-reviewed-article-OTT

Similar Items